Stock Analysis
IDEXX Laboratories, Inc. (IDXX) Stock Analysis
IDEXX Laboratories, Inc. (IDXX) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
IDEXX Laboratories, Inc. (IDXX) currently has an AIQ Score of 44/100, indicating a neutral setup. Quality is the strongest factor at 88/100. Momentum is the weakest current factor at 9/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
IDXX at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $504.70 |
| AIQ Score | 44/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $43B |
| P/E Ratio | 38.34 |
| Forward P/E | — |
| EPS | $4.23 |
| Revenue TTM | $1.22B |
| Dividend Yield | 0.00% |
| Beta | 1.54 |
| Volume | 401.63K |
| 52-week range | $500.61-$769.98 |
| RSI 14 | 23.79 |
| 50-Day SMA | $556.05 |
| 200-Day SMA | $603.46 |
| Analyst Price Target | $656.67 |
| Next Earnings | Nov 2, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
IDXX
OverviewIDXX Stock Analysis Summary
IDEXX Laboratories, Inc. (IDXX) currently has an AIQ Score of 44/100, indicating a neutral setup. Quality is the strongest factor at 88/100. Momentum is the weakest current factor at 9/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, IDXX has AIQ Score of 44/100 with Quality base of 88/100 and fading Momentum at 9/100. Wait for component alignment before adding exposure.
Quality (88/100) leads while Momentum (9/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.36% stock move · IDXX classified in Medical - Diagnostics & Research.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is IDXX Bullish or Bearish Right Now?
IDXX currently has a neutral overall setup. Quality is the strongest factor at 88/100, while Momentum is weakest at 9/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 88/100.
- - Analyst target implies +30.11% upside from the latest quote.
- - Value is the current constraint at 26/100.
- - Momentum is weak at 9/100.
- - Price is -16.37% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (36 vs 8).
Current Consensus
IDXX's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 1 neutral, and 36 sell votes. IDXX's 14-day RSI is 23.79, which places the stock in an oversold momentum range. IDXX's beta is 1.54, indicating greater market sensitivity than the broad market.
What Changed in IDXX?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the IDXX Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
IDXX Decision Framework
Public evidence layers, setup checks, and risk context for IDEXX Laboratories, Inc..
IDEXX Laboratories, Inc. (IDXX) Stock Analysis
IDEXX Laboratories, Inc. has an AIQ Score of 44/100 in a Neutral regime. Quality is strongest at 88/100. Beta is 1.54, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | IDXX is in a Neutral AIQ regime with score 44/100. |
| Signal Conflict | The primary conflict is that quality leads at 88/100 while momentum lags at 9/100. |
| Factor Evidence | Momentum 9/100 · Value 26/100 · Quality 88/100 · Risk 50/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 88/100.
Momentum is 9/100 and RSI (14) is 23.8.
IDXX is in a Neutral regime at 44/100.
Risk factor is 50/100 with beta 1.54 and annual volatility 32.18%.
Current conflict: quality leads at 88/100 while momentum lags at 9/100.
IDXX Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
IDXX Fundamentals
IDXX valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
IDXX Technical Analysis
IDXX technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
IDXX Stock Catalysts
Track IDXX earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
IDXX Dividend Analysis
IDXX dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
IDXX Financial Data
IDXX revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
IDXX Risk Analysis
IDXX volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
IDXX Stock News
IDXX stock news, market tone, recent headlines, and catalyst context.
IDXX vs Medical Devices Peers
Current peer cohort: IDXX · INSP · ISRG · LMAT · MDT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| IDXX Current stock | 44/100 | 26/100 | 9/100 | 50/100 | -0.69 | 32.18% | Current |
| INSP Inspire Medical | 66/100 | 49/100 | 80/100 | 56/100 | 0.18 | 71.15% | IDXX vs INSP |
| ISRG Intuitive Surgical | 49/100 | 26/100 | 32/100 | 64/100 | -0.46 | 36.71% | IDXX vs ISRG |
| LMAT LeMaitre Vascular | 50/100 | 32/100 | 39/100 | 63/100 | -0.17 | 44.78% | IDXX vs LMAT |
| MDT Medtronic | 64/100 | 58/100 | 53/100 | 73/100 | -0.11 | 23.43% | IDXX vs MDT |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching IDXX
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for IDXX
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
IDXX Stock FAQ
What is IDXX stock price today?
IDEXX Laboratories, Inc.'s current stock price is $504.70. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is IDXX bullish or bearish right now?
IDXX's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is IDXX's market cap?
IDXX's market cap is $43B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is IDXX's current P/E ratio?
IDXX's current P/E ratio is 38.34 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is IDXX's RSI?
IDXX's 14-day RSI is 23.79 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is IDXX above its 50-day and 200-day moving averages?
IDXX is -9.23% from its 50-day SMA and -16.37% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is IDXX's next earnings date?
IDXX's next earnings date is currently listed as Nov 2, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does IDXX pay a dividend?
IDXX's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.